DW71177 is a novel [1,2,4]triazolo[4,3-a] quinoxaline-based potent and BD1-Selective BET inhibitor, and can be used for study of acute myeloid leukemia[1].
Molecular Weight:
384.48
Purity:
97.70
CAS Number:
[2241311-72-6]
Formula:
C20H28N6O2
Target:
Epigenetic Reader Domain
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted